Tactics for type I diabetes (Q41603351)

4 October 2017

1 reference

title

Tactics for type I diabetes (English)

1 reference

4 October 2017

0 references

1

Skyler JS

1 reference

4 October 2017

1 September 1997

1 reference

Endocrinology and Metabolism Clinics of North America

4 October 2017

1 reference

4 October 2017

26

1 reference

4 October 2017

3

1 reference

4 October 2017

647-657

1 reference

The impact of the Trial Coordinator in the Diabetes Control and Complications Trial (DCCT). The DCCT Research Group

4 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970272-3

7 January 2021

Nutrition interventions for intensive therapy in the Diabetes Control and Complications Trial. The DCCT Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970272-3

7 January 2021

The pathogenesis of insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970272-3

7 January 2021

Metabolic effects of dietary fructose and sucrose in types I and II diabetic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970272-3

7 January 2021

Metabolic effects of dietary sucrose in type II diabetic subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970272-3

7 January 2021

Clinical experience with a new device that will simplify insulin injections

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970272-3

7 January 2021

Insulin Pharmacokinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970272-3

7 January 2021

The “Dawn Phenomenon” — A Common Occurrence in Both Non-Insulin-Dependent and Insulin-Dependent Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970272-3

7 January 2021

Insulin Treatment of Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970272-3

7 January 2021

Evaluation of glycosylated hemoglobin diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970272-3

7 January 2021

Diet liberalization and metabolic control in type I diabetic outpatients treated by continuous subcutaneous insulin infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970272-3

7 January 2021

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970272-3

7 January 2021

Implementation of treatment protocols in the Diabetes Control and Complications Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970272-3

7 January 2021

Continuous subcutaneous insulin infusion (CSII) versus conventional injection therapy in newly diagnosed diabetic children: two-year follow-up of a randomized, prospective trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970272-3

7 January 2021

Expanded role of the dietitian in the Diabetes Control and Complications Trial: implications for clinical practice. The DCCT Research Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970272-3

7 January 2021

Importance of Timing of Preprandial Subcutaneous Insulin Administration in the Management of Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970272-3

7 January 2021

Nutrition principles for the management of diabetes and related complications

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970272-3

7 January 2021

INSULIN TREATMENT OF DIABETES MELLITUS

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970272-3

7 January 2021

Intensive insulin therapy for treatment of type I diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970272-3

7 January 2021

Insulin prophylaxis in individuals at high risk of type I diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970272-3

7 January 2021

Timing of pre-breakfast insulin injection and postprandial metabolic control in diabetic children.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970272-3

7 January 2021

Nicotinamide treatment in the prevention of insulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970272-3

7 January 2021

The clinical information value of the glycosylated hemoglobin assay

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970272-3

7 January 2021

Continuous subcutaneous insulin infusion: an approach to achieving normoglycaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970272-3

7 January 2021

Multiple daily self-glucose monitoring: its essential role in long-term glucose control in insulin-dependent diabetic patients treated with pump and multiple subcutaneous injections.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970272-3

7 January 2021

The dawn phenomenon, an early morning glucose rise: implications for diabetic intraday blood glucose variation.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970272-3

7 January 2021

Self-monitoring of blood glucose

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970272-3

7 January 2021

Algorithms for adjustment of insulin dosage by patients who monitor blood glucose.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970272-3

7 January 2021

Reduction to normal of plasma glucose in juvenile diabetes by subcutaneous administration of insulin with a portable infusion pump

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970272-3

7 January 2021

Home blood glucose monitoring

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970272-3

7 January 2021

Infant Feeding in Finnish Children <7 yr of Age With Newly Diagnosed IDDM

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970272-3

7 January 2021

Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970272-3

7 January 2021

Prophylactic insulin treatment in relatives at high risk for type 1 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970272-3

7 January 2021

10.1016/S0889-8529(05)70272-3

Identifiers

DOI

1 reference

4 October 2017

1 reference

PubMed ID

9314020